NASDAQ : ABOS

Acumen Pharmaceuticals, Inc.

$2.25 USD

$0.08 (3.69%)

Volume
305.2K
Average Volume
450.32K
Market Capitalization
$136.29M
P/E Ratio
-1.20
Dividend Yield
0.00%
Price Target
$7.00
Year High
$3.60
Year Low
$1.19
Day High
—
Day Low
—
Payout Ratio
$0.00
Current Ratio
$4.55
3333332"{? p/.m7yd f,0=

Annual earnings financials

ABOS financial data with annual/quarterly toggle

ABOS GAAP EPS - Annual & Quarterly

ABOS Sales Revenue - Annual & Quarterly

ABOS Shares Outstanding - Annual & Quarterly

Hover over bars to see exact values. Data includes up to 12 years of annual financials and up to 20 quarters of quarterly data from FMP Financial Data.

ABOS Estimated and Actual Revenue by Quarter
ABOS Estimated and Actual EPS by Quarter
ABOS Analyst Forecasts — EBITDA & EBIT
Quarter Date No of Estimates Ebitda Ebit
Low High Average Low High Average
2027-12-31 0 - - - - - -
2027-09-30 0 - - - - - -
2027-06-30 0 - - - - - -
2027-03-31 0 - - - - - -
2026-12-31 0 - - - - - -
2026-09-30 0 - - - - - -
ABOS Analyst Forecasts — Net Income & SGA Expense
Quarter Date No of Estimates NetIncome SgaExpense
Low High Average Low High Average
2027-12-31 0 -15.49M -15.49M -15.49M - - -
2027-09-30 0 -14.86M -14.86M -14.86M - - -
2027-06-30 0 -13.91M -13.91M -13.91M - - -
2027-03-31 0 -14.54M -14.54M -14.54M - - -
2026-12-31 0 -23.6M -23.6M -23.6M - - -
2026-09-30 0 -23.81M -23.81M -23.81M - - -
ABOS Analyst Forecasts — Revenue & EPS
Quarter Date No of Revenue Estimates Revenue No of EPS Estimates EPS
Low High Average Low High Average
2027-12-31 0 - - - 1 -0.245 -0.245 -0.245
2027-09-30 0 - - - 1 -0.235 -0.235 -0.235
2027-06-30 0 - - - 1 -0.22 -0.22 -0.22
2027-03-31 0 - - - 1 -0.23 -0.23 -0.23
2026-12-31 0 - - - 1 -0.37329 -0.37329 -0.37329
2026-09-30 0 - - - 2 -0.37662 -0.37662 -0.37662